Composition
- Active ingredients
- ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN 10MG/0.5ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761179.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Rylaze
- Active substance
- asparaginase erwinia chrysanthemi (recombinant)-rywn
- Route
- Intramuscular
- Dosage form
- Injectable
- Applicant
- Jazz Pharms
- Status
- Prescription
- FDA approval
- 30 Jun 2021
- Application
- BLA761179-001